Home » Clinical Trials »  Search Clinical Trials

Therapeutic Areas:  |  Endocrinology  |  Family Medicine

Search Medical Condition
Please enter condition
Please choose location from dropdown
Clear Trial Filters

Diabetes Mellitus, Type 2 Clinical Trials

A listing of Diabetes Mellitus, Type 2 medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.


Found (11) clinical trials

The research is being done to test whether the active study drug is safe in patients who have diabetes, kidney disease and who are at risk for cardiovascular events such as heart attack and stroke.


Strategies To OPpose SUGARS With Non-nutritive Sweeteners Or Water (STOP SUGARS NOW) Trial

BACKGROUND AND SIGNIFICANCE: International health agencies and chronic disease associations have called for reductions in free/added sugars to 5-10% of energy to address the growing epidemics of obesity and diabetes. Attention has focused especially on the reduction of the major source of free sugars, sugar sweetened beverages (SSBs), the excess ...

Phase N/A

DISCOVER Global Registry

The registry intends to provide real world data on patient characteristics, disease management, healthcare utilization, and outcomes in patients with type 2 diabetes and established micro- and/or macrovascular disease. Countries involved may vary depending on the interest shown by investigators and authorities all over the world

Phase N/A

Study to Develop a Kinetic Model for FDG and Me4FDG in Kidneys of Type 2 Diabetic Patients

Independent of insulin, inhibition of sodium-glucose transporter 2 (SGLT2) in the proximal tubular cells prevents glucose reabsorption and promotes glucose excretion by causing glycosuria. Therefore, SGLT2 inhibitors known as Gliflozine are recently authorized for the treatment of type 2 diabetes mellitus (DM), whether as monotherapy or in combination with other ...

Phase N/A

Personalised Medicine in Pre-diabetes and Early Type 2 Diabetes

Prediabetes is common in overweight and obese individuals and, as with frank diabetes, it is a risk factor for cardiovascular disease, cognitive dysfunction, fatty liver, kidney, ophthalmic, renal and neuropathic disease, and cancer. Effective management of dysglycemia in pre-diabetes and diabetes and prevention of diabetes in individuals at risk reduce ...

Phase N/A

The Set-Point Study for Type 2 Diabetes: Evaluating the Use of an Insulin Only Bionic Pancreas System in Type 2 Diabetes

The study will consist of two 7 day study arms: one usual care, and one insulin-only bionic pancreas at a set point of 100 mg/dl. The co-primary outcomes will be the mean Dexcom CGM glucose level and time <54 mg/dl, both in the last five days of each arm because ...

Phase N/A

Effects of a Carbonated Water Enriched With Amino Acids and Chromium Picolinate (Good Idea ) on Glucose Homeostasis.

It has previously been shown in healthy subjects, that a carbonated water containing a mix of amino acids and chromium picolinate can decrease postprandial blood glucose. Based on these findings, a flavored sparkling water product called Good Idea with a proprietary blend of five amino acids and chromium picolinate has ...

Phase N/A

A Study to Investigate the Effect of MEDI0382 on Hepatic Glycogen Metabolism in Overweight and Obese Subjects With Type 2 Diabetes Mellitus.

This is a 2-part exploratory Phase 2 study. Part A is a randomised, double-blind, placebo-controlled study to evaluate the effect of MEDI0382 administered once daily subcutaneously (SC) for 28 days on hepatic glycogen metabolism in overweight and obese subjects with T2DM. Part A is planned to randomise up to 16 ...